Identification of specific calcium-binding noncollagenous proteins associated with glutaraldehyde-preserved bovine pericardium in the rat subdermal model

Journal of Biomedical Materials Research

Volumn 35, Issue 4, 1997, Pages 483-495

  Gura, Trisha A ^a   Wright, Karen L ^a   Veis, Arthur ^b   Webb, Catherine L ^a  

^a CHILDREN'S MEMORIAL HOSPITAL   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDES; ANTIBODIES; BONE; CALCIFICATION (BIOCHEMISTRY); CALCIUM; ELECTROPHORESIS; EXTRACTION; HEART VALVE PROSTHESES; IMMUNOLOGY; IMPLANTS (SURGICAL); MINERALS; PHYSIOLOGICAL MODELS;

BONE ACIDIC GLYCOPROTEIN 75; BOVINE PERICARDIUM; GLUTARALDEHYDE; IMMUNOHISTOCHEMISTRY; NONCOLLAGENOUS PROTEINS; OSTEOPONTIN; SIALOPROTEIN II; WESTERN BLOTTING;

PROTEINS;

CALCIUM BINDING PROTEIN; GLUTARALDEHYDE;

ANIMAL CELL; ANIMAL TISSUE; BIOPROSTHESIS; BONE MINERALIZATION; CALCIFICATION; CATTLE; CONFERENCE PAPER; HEART VALVE PROSTHESIS; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PATHOPHYSIOLOGY; PROSTHESIS FAILURE; PROTEIN DETERMINATION; RAT;

ANIMALS; CALCIFICATION, PHYSIOLOGIC; CALCIUM; CALCIUM-BINDING PROTEINS; CATTLE; COLLAGEN; GLUTARAL; HYDROGEN-ION CONCENTRATION; KINETICS; MODELS, BIOLOGICAL; PERICARDIUM; PHOSPHORYLATION; RATS;

EID: 8244251431     PISSN: 00219304     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4636(19970615)35:4<483::AID-JBM8>3.0.CO;2-D     Document Type: Conference Paper

References (60)

1. A. Milano, U. Bortolotti, E. Talenti, C. Valfre, E. Arbustini, M. Valente, A. Mazzucco, V. Gallucci, and G. Thiene, "Calcific degeneration as the main cause of porcine bioprosthetic valve dysfunction," Am. J. Cardiol., 53, 1066-1070 (1984).
2. F. J. Schoen, "Cardiac valve prosthesis: Review of clinical status and contemporary biomaterials issues," J. Biomed. Mater. Res. Appl. Biomater., 21, 91-117 (1987).
3. S. P. Sanders, R. J. Levy, M. D. Freed, W. I. Norwood, and A. R. Castaneda, "Use of Hancock porcine xenografts in children and adolescents," Am. J. Cardiol., 46, 429-438 (1980).
4. R. J. Levy, F. J. Schoen, H. C. Anderson, H. Harasaki, T. G. Koch, W. Brown, J. B. Lian, R. Cumming, and J. B. Gavin, "Cardiovascular implant calcification: A survey and update," Biomaterials, 12, 707-714 (1991).
5. G. A. Rodan, "Introduction to bone biology," Bone, 13, S3-S6 (1992).
6. S. B. Rodan, G. Wesolowski, K. Yoon, and G. A. Rodan, "Growth stimulation of rat calvaria osteoblastic cells by acidic fibroblast growth factor," Endocrinology, 121, 1917-1923 (1987).
7. M. Centrella, T. L. McCarthy, and E. Canalis, "Skeletal tissue and transforming growth factor β," FASEB J., 2, 3066-3073 (1988).
8. C.-H. Heldin, B. Westermark, and A. Wasteson, "Chemical and biological properties of a growth factor from human-cultured osteosarcoma cells: Resemblance with platelet-derived growth factor," J. Cell. Physiol., 105, 235-246 (1980).
9. A. Boskey, "Noncollagenous matrix proteins and their role in mineralization," Bone and Mineral, 6, 111-123 (1989).
10. M. F. Young, J. M. Kerr, I. Kyomi, A. Heegarrd, and P. G. Robey, "Structure, expression, and regulation of the major noncollagenous matrix proteins of bone," Clin. Orthop. Rel. Res., 281, 275-294 (1992).
11. A. Endo and M. J. Glimcher, "The effect of complexing phosphoproteins to decalcified collagen on in vitro calcification," Connect. Tiss. Res., 21, 179-196 (1989).
12. J. D. Termine, H. K. Kleinman, S. W. Whitson, K. M. Conn, M. L. McGarvey, and G. R. Martin, "Osteonectin, a bone specific protein linking mineral to collagen," Cell, 26, 99-105 (1981).
13. R. W. Romberg, P. G. Wemess, P. Lollar, B. L. Riggs, and K. G. Mann, "Isolation and characterization of native adult osteonectin," J. Biol. Chem., 260, 2728-2736 (1985).
14. 2+ 1-binding protein SPARC (Osteonectin) revealed by in situ hybridization," J. Cell Biol., 105, 473-482 (1987).
15. M. Ringuette, S. Damjanovski, and D. Wheeler, "Expression of SPARC/osteonectin in tissues of bony and cartilaginous vertebrates," Biochem. Cell Biol., 69, 245-250 (1991).
16. E. H. Sage, R. Vernon, J. Decker, S. Funk, and M. L. Iruela-Arispe, "Distribution of the calcium-binding protein SPARC in tissues of embryonic and adult mice," J. Histochem. Cytochem., 37, 819-829 (1989).
17. S. E. Funk and E. H. Sage, "The Ca2+-biding glycoprotein SPARC modulates cell cycle progression in bovine aortic endothelial cells," Proc. Natl. Acad. Sci. USA, 88, 2648-2652 (1991).
18. T. F. Lane, M. L. Iruela-Arispe, and E. H. Sage, "Regulation of gene expression by SPARC during angiogenesis in vitro," J. Biol. Chem., 267, 16736-16745 (1992).
19. W. T. Butler, "The nature and significance of osteopontin," Connect. Tiss. Res., 23, 123-136 (1989).
20. F. P. Reinholt, K. Hultenby, A. Oldeberg, and D. Heinegard, "Osteopontin - A possible anchor of osteoclasts to bone," Proc. Natl. Acad. Sci. USA, 87, 4473-4475 (1990).
21. J. P, Gorski and K. Shimizu, "Isolation of a new phosphorylated glycoprotein from the mineralized phase of bone that exhibits limited homology to the adhesive protein osteopontin," J. Biol. Chem., 263, 15938-15945 (1988).
22. J. P. Gorski, D. Griffin, G. Dudley, C. Stanford, R. Thomas, C. Huang, E. Lai, B. Karr, and M. Solursh, "Bone acidic glycoprotein-75 is a major synthetic product of osteoblastic cells and localized as 75- and/or 50kDa forms in mineralized phases of bone and growth plate and in serum," J. Biol. Chem., 265, 14956-14963 (1990).
23. M. Sato, W. Grasser, S. Harm, C. Fullenkamp, and J. P. Gorski, "Bone acidic glycoprotein 75 inhibits resorption activity of isolated rat and chicken osteoclasts," FASEB J., 6, 2966-2976 (1992).
24. A. Oldberg, A. Franzen, and D. Heinegard, "The primary structure of a cell-binding bone sialoprotein," J. Biol. Chem., 263, 19430-19432 (1988).
25. P. Bianco, L. W. Fisher, M. F. Young, J. D. Termine, and P. G. Robey, "Expression of bone sialoprotein in developing human tissues," Calcif. Tissue Int., 49, 421-426 (1991).
26. F. J. Schoen, R. J. Levy, A. C. Nelson, W. F. Bernhard, A. Nashef, and M. Hawley, "Onset and progression of experimental heart valve calcification," Lab. Invest., 52, 523-532 (1985).
27. F. J. Schoen, J. W. Tsao, and R. J. Levy, "Calcification of bovine pericardium used in cardiac valve bioprostheses: Implications for the mechanisms of bioprosthetic tissue mineralization," Am. J. Pathol., 123, 134-145 (1986).
28. F. J. Schoen and R. J. Levy, "Bioprosthetic heart valve calcification: Membrane-mediated events and alkaline phosphatase," Bone and Mineral, 17, 129-133 (1992).
29. C. L. Webb, F. J. Schoen, and R. J. Levy, "Covalent binding of aminopropanehydroxydiphosphonate to glutaraldehyde residues in pericardial bioprosthetic tissue: Stability and calcification inhibition studies," Exp. Molec. Pathol., 50, 291-302 (1989).
30. J. D. Termine, A. B. Belcourt, K. M. Conn, and H. K. Kleinman, "Mineral and collagen-binding proteins of fetal calf bone," J. Biol. Chem., 256, 10403-10408 (1981).
31. 4," Nature, 227, 680-685 (1970).
32. M. R. Green and J. V. Pastewka, "Differential staining by a cationic carbocyanine dye of nucleic acids, proteins, and conjugated proteins: I. Phosphoproteins," J. Histochem. Cytochem., 22, 767-781.
33. H. Towbin, T. Staehlin, and J. Gordon, "Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications," Proc. Natl. Acad. Sci. USA, 76, 4350-4354 (1974).
34. D. R. Senger, C. A. Perruzzi, C. F. Gracey, A. Papadopoulos, and D. G. Tenen, "Secreted phosphoproteins associated with neoplastic transformation: Close homology with plasma proteins cleaved during blood coagulation," Cancer Res., 48, 5770-5774, (1988).
35. G. Golomb, F. J. Schoen, M. S. Smith, J. Linden, M. Dixon, and R. G. Levy, "The role of glutaraldehyde-induced crosslinks in calcification of bovine pericardium used in cardiac valve bioprosthesis," Am. J. Pathol., 127, 122-130 (1987).
36. N.M. Ritter, M. C. Farach-Carson, and W. T. Butler, "Evidence for the formation of a complex between osteopontin and osteocalcin," J. Bone Mineral Res., 7, 877-885 (1992).
37. L. Malaval, B. Fournier, and P. D. Delmos, "Radioimmunoassay for ostenoectin: Concentrations in bone, nonmineralized tissues, and blood," J. Bone Tiss. Res., 2, 457-465 (1987).
38. Y. Chen, B. S. Bal, and J. P. Gorski, "Calcium and collagen binding properties of osteopontin, bone sialoprotein, and bone acidic glycoprotein-75 from bone," J. Biol. Chem., 267, 1-8 (1992).
39. A.-P. Gadeau, M. Campan, D. Millet, T. Candresse, and C. Desgranges, "Osteopontin overexpression is associated with arterial smooth muscle cell proliferation in vitro. Arteriosclerosis and Thrombosis," 13, 120-125 (1993).
40. M. Weinreb, D. Shinar, and G. A. Rodan, "Different pattern of alkaline phosphatase, osteopontin, and osteocalcin expression in developing rat bone visualized by in situ hybridization," J. Bone Min. Res., 5, 831-842 (1990).
41. L. C. Gerstenfeld, Y. Gotoh, M. D. McKee, A. Nanci, W. J. Landis, and M. J. Glimcher, "Expression of a major 66kD phosphoprotein synthesized by chicken osteoblasts during mineralization in vitro," Anat. Rec., 228, 93-103 (1990).
42. r 43,000 glycoprotein ligand," J. Cell. Physiol., 127, 373-387 (1986).
43. J. Engel, W. Taylor, M. Paulsson, E. H. Sage, and B. L. M. Hogan, "Calcium-binding domains and calcium-induced transition in SPARC (osteonectin, BM-40), an extracellular glycoprotein expressed in mineralized and nonmineralized tissues," Biochem., 26, 6958-6965 (1987).
44. B. L. M. G. Gijsbers, L. J. M. van Haarlem, B. A. M. Soute, R. H. M. Ebberink, and C. Vermeer, "Characterization of a Gla-containing protein from calcified human atherosclerotic plaques," Arteriosclerosis, 10, 991-995 (1990).
45. R. J. Levy, C. M. Gundberg, and R. Scheinman, "The identification of the vitamin K-dependent bone-protein osteocalcin as one of the gammacarboxyglutamic acid-containing proteins present in calcified atherosclerotic plaque and mineralized heart valves," Atherosclerosis, 46, 49-56 (1983).
46. R. Romero, J. M. Augustyn, and G. Mandel, "Isolation and characterization of human apatite-inducing aortic proteolipid," Exp. Molec. Pathol., 51, 149-158 (1989).
47. M. E. Nimni, D. Ertl, J. Villanueva, and B. S. Nimni, "Inhibition of ectopic calcification of glutaraldehyde crosslinked collagen and collagenous tissues by a covalently bound diphosphonate," Am. J. Cardiovasc., 3, 237-245 (1990).
48. R. J. Levy, F. J. Schoen, J. T. Levy, A. C. Nelson, S. L. Howard, and L. J. Oshry, "Biologic determinants of dystrophic calcification and osteocalcin deposition in glutaraldehyde-preserved porcine aortic valve leaflets implanted subcutaneously in rats," Am. J. Pathol., 113, 143-155 (1983).
49. J. B. Lian, G. Boivin, P. Patterson-Allen, M. Grynpas, and C. Walzer, "Calcergy and calciphylaxis: Timed appearance of gamma-carboxyglutamic acid and osteocalcin in mineral deposits," Calcif. Tiss. Int., 35, 555-561 (1983).
50. J. P. Gorski, "Proteolytic inactivation of matrix metalloproteinase 3 (Stromelysin) by BAG 75," presented at Midwestern Connective Tissue Workshop, Rush Presbyterian-St. Luke's Medical Center, Chicago, Illinois, October 23-24, 1992.
51. C. M. Shanahan, N. R. B. Cary, J. C. Metcalfe, and P. L. Weissberg, "High expression of genes for calcification-regulating proteins in human atherosclerotic plaques," J. Clin Invest., 93, 2392-2402 (1994).
52. 2+ diphosphonate pretreatment," J. Pharm. Sci., 77, 740-744 (1988).
53. 3 in rat subdermal model studies," Am. J. Pathol., 138, 971-981 (1991).
54. 3+ in rat subdermal implants of glutaraldehyde-preserved bovine pericardium," Trans. Am. Soc. Artif. Intern. Org., 37, M170-M172 (1991).
55. G. Golomb, I. Lewinstein, V. Ezra, and F. J. Schoen, "Mechanical properties and histology of charge modified bioprosthetic tissue resistant to calcification," Biomaterials, 13, 353-356 (1992).
56. M. J. Thurbrikar, S. P. Nolan, and J. D. Deck, "Intrinsic calcification of T6-processed and control porcine and bovine bioprostheses in calves," Trans. Am. Soc. Artif. Intern. Org., 29, 245-249 (1983).
57. M. Grimm, M. Grabenwoger, E. Eybl, A. Moritz, P. Bock, M. M. Muller, and E. Wolner, "Improved biocompatibility of bioprosthetic heart valves by L-glutamic acid treatment," J. Cardiovasc. Surg., 7, 58-64 (1992).
58. J. W. Tsao, F. J. Schoen, R. Shankar, J. D. Sallis, and R. J. Levy, "Retardation of calcification of bovine pericardium used in bioprosthetic heart valves by phosphocitrate and a synthetic analogue," Biomaterials, 9, 393-397 (1988).
59. J. P. Gott, Pan-Chih, L. M. A. Dorsey, J. L. Jay, G. K. Jett, F. J. Schoen, J.-M. Giradot, and R. A. Guyton, "Calcification of porcine valves: A successful new method of antimineralization," Ann. Thorac. Surg., 53, 207-216 (1992).
60. L. W. Fisher, "Structure/function studies of the sialoglycoproteins and proteoglycans of bone: It is still in the early days," in Chemistry and Biology of Mineralized Tissues, Elsevier Science Publishing, Amsterdam, 1992, pp. 177-186.